Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclophosphamide Adverse Reaction”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Large-scale testing (Phase 3)UnknownNCT05158608
What this trial is testing

Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Who this might be right for
Graft Versus Host DiseaseHematologic MalignancyCyclophosphamide Adverse Reaction
National Research Center for Hematology, Russia 100
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Testing effectiveness (Phase 2)Looking for participantsNCT07169851
What this trial is testing

Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Who this might be right for
NauseaVomitingDrug-Related Side Effects and Adverse Reactions+1 more
Eli Lilly and Company 204
Not applicableStudy completedNCT04568161
What this trial is testing

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Who this might be right for
CardiotoxicityCardiovascular DiseaseNeurovascular Disorder+2 more
University of Sao Paulo General Hospital 15
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Not applicableUnknownNCT01246856
What this trial is testing

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study

Who this might be right for
Breast Cancer
Radboud University Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Not applicableUnknownNCT05150080
What this trial is testing

Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity

Who this might be right for
Cardio-oncologyHematopoietic Stem Cell TransplantationCardiotoxicity+2 more
Kai Mu 40